Benzinga | Aug 12, 2020 04:14PM EDT

ClearPoint Neuro Q2 EPS $(0.11) Beats $(0.16) Estimate, Sales $1.59M Miss $1.88M Estimate

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.16) by 31.25 percent. This is a 15.38 percent increase over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $1.59 million which missed the analyst consensus estimate of $1.88 million by 15.27 percent. This is a 38.87 percent decrease over sales of $2.61 million the same period last year.